This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Anchen Laboratories, Inc., Industrial Technology Research Institute. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 9,303 
Years Active: 2011-2013
Title: Yow-Lone Chang: Innovator in Azaazulene Compounds and GABA Analogs
Introduction
Yow-Lone Chang is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment. With a total of 2 patents, his work reflects a commitment to advancing medical science.
Latest Patents
Chang's latest patents include innovative compounds that are designed to address critical health issues. One of his patents focuses on azaazulene compounds, which are characterized by a specific formula. These compounds can be utilized in treating cancer, and the invention also outlines a method for administering these compounds effectively to patients in need. Another patent involves GABA analogs, which includes pharmaceutical compositions and methods for their synthesis. These advancements highlight Chang's dedication to improving therapeutic options for patients.
Career Highlights
Throughout his career, Yow-Lone Chang has worked with esteemed organizations such as the Industrial Technology Research Institute and Anchen Laboratories, Inc. His experience in these institutions has allowed him to collaborate with other professionals and contribute to groundbreaking research in his field.
Collaborations
Chang has collaborated with notable colleagues, including On Lee and Chih-Hung Chen. These partnerships have played a crucial role in the development of his innovative patents and have fostered a collaborative environment for research and development.
Conclusion
Yow-Lone Chang's contributions to the field of pharmaceuticals, particularly through his patents on azaazulene compounds and GABA analogs, demonstrate his innovative spirit and commitment to advancing medical science. His work continues to inspire future research and development in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile